iBet uBet web content aggregator. Adding the entire web to your favor.
iBet uBet web content aggregator. Adding the entire web to your favor.



Link to original content: http://www.ncbi.nlm.nih.gov/pubmed/28262699
GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses - PubMed Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Mar 6:7:43395.
doi: 10.1038/srep43395.

GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses

Michael K Lo  1 , Robert Jordan  2 , Aaron Arvey  2 , Jawahar Sudhamsu  2 , Punya Shrivastava-Ranjan  1 , Anne L Hotard  1 , Mike Flint  1 , Laura K McMullan  1 , Dustin Siegel  2 , Michael O Clarke  2 , Richard L Mackman  2 , Hon C Hui  2 , Michel Perron  2 , Adrian S Ray  2 , Tomas Cihlar  2 , Stuart T Nichol  1 , Christina F Spiropoulou  1
Affiliations

GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses

Michael K Lo et al. Sci Rep. .

Abstract

GS-5734 is a monophosphate prodrug of an adenosine nucleoside analog that showed therapeutic efficacy in a non-human primate model of Ebola virus infection. It has been administered under compassionate use to two Ebola patients, both of whom survived, and is currently in Phase 2 clinical development for treatment of Ebola virus disease. Here we report the antiviral activities of GS-5734 and the parent nucleoside analog across multiple virus families, providing evidence to support new indications for this compound against human viruses of significant public health concern.

PubMed Disclaimer

Conflict of interest statement

The authors affiliated with Gilead Sciences are employees of the company and may own company stock.

Figures

Figure 1
Figure 1. Structural analysis of viral RdRPs nucleotide binding domains.
(A) Structure of nucleotide binding domain of HCV RdRP showing structural elements (motifs A and B) that interact directly with the nucleotide. (B) Structural alignment of nucleotide binding domains of viral RdRPs shows high similarity between numerous structures. (C) Structural alignment of HCV and DenV RdRP nucleotide binding domains. (D) Structural alignment of HCV and VSV RdRP nucleotide binding domains.
Figure 2
Figure 2. GS-5734 potently inhibits multiple virus families.
Clustering by sequence similarity of the nucleotide-interacting regions (motifs A and B) of viral RNA-dependent RNA polymerases correlates with activity of GS-5734 (indicated by color in legend). The tree branches do not necessarily reflect evolutionary relationships (or lack thereof). For details regarding methodology, please refer to methods. †GS-5734 EC50 against MuV is higher than 100 nM, with EC50 of 0.79 μM. ‡GS-5734 is potent (EC50 < 4.5 μM) against AHFV, KFDV, TBEV, and OHFV. The parent nucleoside (Nuc) of GS-5734 is also active against DenV and HCV, but not WNV or YFV.
See this image and copyright information in PMC

Similar articles

  • Mechanism of Inhibition of Ebola Virus RNA-Dependent RNA Polymerase by Remdesivir.
    Tchesnokov EP, Feng JY, Porter DP, Götte M. Tchesnokov EP, et al. Viruses. 2019 Apr 4;11(4):326. doi: 10.3390/v11040326. Viruses. 2019. PMID: 30987343 Free PMC article.
  • Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys.
    Warren TK, Jordan R, Lo MK, Ray AS, Mackman RL, Soloveva V, Siegel D, Perron M, Bannister R, Hui HC, Larson N, Strickley R, Wells J, Stuthman KS, Van Tongeren SA, Garza NL, Donnelly G, Shurtleff AC, Retterer CJ, Gharaibeh D, Zamani R, Kenny T, Eaton BP, Grimes E, Welch LS, Gomba L, Wilhelmsen CL, Nichols DK, Nuss JE, Nagle ER, Kugelman JR, Palacios G, Doerffler E, Neville S, Carra E, Clarke MO, Zhang L, Lew W, Ross B, Wang Q, Chun K, Wolfe L, Babusis D, Park Y, Stray KM, Trancheva I, Feng JY, Barauskas O, Xu Y, Wong P, Braun MR, Flint M, McMullan LK, Chen SS, Fearns R, Swaminathan S, Mayers DL, Spiropoulou CF, Lee WA, Nichol ST, Cihlar T, Bavari S. Warren TK, et al. Nature. 2016 Mar 17;531(7594):381-5. doi: 10.1038/nature17180. Epub 2016 Mar 2. Nature. 2016. PMID: 26934220 Free PMC article.
  • Oral administration of obeldesivir protects nonhuman primates against Sudan ebolavirus.
    Cross RW, Woolsey C, Chu VC, Babusis D, Bannister R, Vermillion MS, Geleziunas R, Barrett KT, Bunyan E, Nguyen AQ, Cihlar T, Porter DP, Prasad AN, Deer DJ, Borisevich V, Agans KN, Martinez J, Harrison MB, Dobias NS, Fenton KA, Bilello JP, Geisbert TW. Cross RW, et al. Science. 2024 Mar 15;383(6688):eadk6176. doi: 10.1126/science.adk6176. Epub 2024 Mar 15. Science. 2024. PMID: 38484056
  • Will There Be a Cure for Ebola?
    Cardile AP, Warren TK, Martins KA, Reisler RB, Bavari S. Cardile AP, et al. Annu Rev Pharmacol Toxicol. 2017 Jan 6;57:329-348. doi: 10.1146/annurev-pharmtox-010716-105055. Epub 2016 Dec 7. Annu Rev Pharmacol Toxicol. 2017. PMID: 27959624 Review.
  • Filovirus proteins for antiviral drug discovery: Structure/function bases of the replication cycle.
    Martin B, Canard B, Decroly E. Martin B, et al. Antiviral Res. 2017 May;141:48-61. doi: 10.1016/j.antiviral.2017.02.004. Epub 2017 Feb 10. Antiviral Res. 2017. PMID: 28192094 Review.
See all similar articles

Cited by

See all "Cited by" articles

References

    1. Cihlar T. & Ray A. S. Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine. Antiviral Res 85, 39–58 (2010). - PubMed
    1. Eltahla A. A., Luciani F., White P. A., Lloyd A. R. & Bull R. A. Inhibitors of the Hepatitis C Virus Polymerase; Mode of Action and Resistance. Viruses 7, 5206–5224 (2015). - PMC - PubMed
    1. Cho A. et al.. Synthesis and antiviral activity of a series of 1′-substituted 4-aza-7,9-dideazaadenosine C-nucleosides. Bioorg Med Chem Lett 22, 2705–2707 (2012). - PMC - PubMed
    1. Warren T. K. et al.. Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys. Nature 531, 381–385 (2016). - PMC - PubMed
    1. Lo M. K., Nichol S. T. & Spiropoulou C. F. Evaluation of luciferase and GFP-expressing Nipah viruses for rapid quantitative antiviral screening. Antiviral Res 106, 53–60 (2014). - PMC - PubMed

Publication types

MeSH terms